New data from one of the larger studies of prostate cancer screening are showing that the commonly used PSA blood test may not save lives, reports The New York Times.
The verdict that healthy men shouldn't get the prostate-specific antigen test, or PSA blood test, came down from the United States Preventive Services Task Force. Its conclusions was based on five clinical trials, which showed that while PSA screening did detect more cancers, it didn't save more lives as compared with a group of men that received routine medical care.

